Herm J. Lamberink
Papers
1
Total Citations
17
H-Index
1
About
Herm J. Lamberink is a leading figure in metascience and research integrity, whose work has fundamentally reshaped how we understand the prevalence of questionable research practices in clinical trials. His landmark 2022 study, which has garnered 17 citations and widespread attention, systematically analyzed over 163,000 randomized controlled trials to identify indicators of bias and misconduct. By examining risk of bias in domains like random sequence generation, allocation concealment, and blinding, Lamberink provided the first large-scale empirical evidence of the scale of QRPs in medical research. This work has become a cornerstone for initiatives aimed at improving reproducibility and transparency. Beyond this flagship study, Lamberink’s research bridges data science and meta-research, developing tools to detect statistical anomalies and methodological flaws. His contributions have been instrumental in guiding policy changes at journals and funding agencies, making him a key voice in the movement toward more trustworthy science. For students and researchers, Lamberink’s work serves as both a cautionary tale and a call to action, demonstrating how rigorous meta-research can safeguard the integrity of evidence-based medicine.
Research Focus
Key Achievements
Top Papers
- 1